- Home
- ONTF vs ARTV Comparison
ONTF vs ARTV Comparison
Compare ONTF & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONTF
- ARTV
- Stock Information
- Founded
- ONTF 1998
- ARTV 2019
- Country
- ONTF United States
- ARTV United States
- Employees
- ONTF N/A
- ARTV N/A
- Industry
- ONTF Computer Software: Prepackaged Software
- ARTV
- Sector
- ONTF Technology
- ARTV
- Exchange
- ONTF Nasdaq
- ARTV NYSE
- Market Cap
- ONTF 221.7M
- ARTV 50.7M
- IPO Year
- ONTF 2021
- ARTV 2024
- Fundamental
- Price
- ONTF $5.49
- ARTV $1.47
- Analyst Decision
- ONTF Hold
- ARTV Strong Buy
- Analyst Count
- ONTF 4
- ARTV 8
- Target Price
- ONTF $5.33
- ARTV $18.14
- AVG Volume (30 Days)
- ONTF 253.1K
- ARTV 297.9K
- Earning Date
- ONTF 08-05-2025
- ARTV 05-08-2025
- Dividend Yield
- ONTF N/A
- ARTV N/A
- EPS Growth
- ONTF N/A
- ARTV N/A
- EPS
- ONTF N/A
- ARTV N/A
- Revenue
- ONTF $145,087,000.00
- ARTV N/A
- Revenue This Year
- ONTF N/A
- ARTV N/A
- Revenue Next Year
- ONTF N/A
- ARTV N/A
- P/E Ratio
- ONTF N/A
- ARTV N/A
- Revenue Growth
- ONTF N/A
- ARTV N/A
- 52 Week Low
- ONTF $4.35
- ARTV $1.47
- 52 Week High
- ONTF $7.04
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- ONTF 53.83
- ARTV N/A
- Support Level
- ONTF $5.21
- ARTV N/A
- Resistance Level
- ONTF $5.45
- ARTV N/A
- Average True Range (ATR)
- ONTF 0.15
- ARTV 0.00
- MACD
- ONTF -0.02
- ARTV 0.00
- Stochastic Oscillator
- ONTF 50.00
- ARTV 0.00
About ONTF ON24 Inc.
ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The Company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).